NCT07143617View on ClinicalTrials.gov

Exploratory Clinical Study on the Safety of STR-P004

NANot yet recruitingINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

March 15, 2026

Study Completion Date

September 14, 2026

Conditions

Autoimmune Diseases

Interventions

BIOLOGICAL

STR-P004

STR-P004 Intravenous infusion

Sponsors

Collaborators (1)

Starna Therapeutics

All Listed Sponsors

collaborator

Starna Therapeutics

INDUSTRY

lead

Beijing GoBroad Hospital

OTHER

NCT07143617 - Exploratory Clinical Study on the Safety of STR-P004 | Biotech Hunter | Biotech Hunter